Literature DB >> 3292634

Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses.

M M Pienkowski1, N F Adkinson, M Plaut, P S Norman, L M Lichtenstein.   

Abstract

With a skin blister technique in which the mediators generated by the trauma of forming the blister are allowed to subside, we have collected human interstitial skin fluid during the course of allergic reactions to ragweed, and measured levels of histamine and prostaglandin D2 (PGD2). Of 18 ragweed-allergic individuals tested, 11 developed both an immediate and a late-phase reaction (LPR) with fivefold-elevated levels of histamine (40 ng/ml) at 30 minutes and a peak level of PGD2 (6.5 ng/ml) later at 2 1/2 hours after ragweed challenge. The other seven allergic individuals had immediate reactions without an LPR lesion and demonstrated somewhat smaller elevations of histamine (25 ng/ml) but much lower levels of PGD2 (1.6 ng/ml; p less than 0.05). The time course of appearance of these mediators was identical in both groups of patients. The fluids from unchallenged blisters of allergic and nonallergic patients and the fluids of nonallergic patients challenged with ragweed had similar levels of histamine, at the lower limit of detection, and undetectable PGD2 levels. The peak levels of PGD2 in allergic individuals correlated with the size of the LPR lesion (p less than 0.05). These data suggest that the LPR involves the secondary elaboration of mediators different from mediators responsible for the immediate manifestations of the allergic skin reaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292634     DOI: 10.1016/0091-6749(88)90057-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammation.

Authors:  S R Lessin; B M Benoit; G Li; A Moskovitz; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

2.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

Authors:  E N Charlesworth; A F Hood; N A Soter; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.

Authors:  P G Hellewell; P J Jose; T J Williams
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

Review 4.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

5.  9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.

Authors:  Marita Nittner-Marszalska; Ewa Cichocka-Jarosz; Marek Sanak; Magdalena Wujczyk; Anna Dor-Wojnarowska; Grzegorz Lis; Jerzy Liebhart
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-03-13       Impact factor: 4.291

6.  DP1 receptor signaling prevents the onset of intrinsic apoptosis in eosinophils and functions as a transcriptional modulator.

Authors:  Miriam Peinhaupt; David Roula; Anna Theiler; Miriam Sedej; Rudolf Schicho; Gunther Marsche; Eva M Sturm; Ian Sabroe; Marc E Rothenberg; Akos Heinemann
Journal:  J Leukoc Biol       Date:  2018-04-01       Impact factor: 4.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.